United Therapeutics Corporation (UTHR) financial statements (2021 and earlier)

Company profile

Business Address 1040 SPRING ST
SILVER SPRING, MD 20910
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,8351,4861,4169271,051954696
Cash and cash equivalents7397386697051,023832398
Short-term investments1,09674874722228122298
Receivables157151176297215193162
Inventory, net of allowances, customer advances and progress billings87931011081008167
Inventory87931011081008167
Other current assets8813475116604749
Total current assets:2,1671,8651,7681,4481,4251,275974
Noncurrent Assets
Property, plant and equipment732739700546489496478
Long-term investments and receivables1,150768443503238123
Long-term investments1,150768443503238123
Intangible assets, net (including goodwill), including:15815817146342829
Goodwill28283214101010
Intangible assets, net (excluding goodwill)(6)(5)(5)(9)(9)34
Other undisclosed intangible assets, net (including goodwill)13613614441321616
Deferred income tax assets239230
Other noncurrent assets17015522422419715498
Deferred tax assets, net96113178193182
Total noncurrent assets:2,4482,0491,6331,432901909910
TOTAL ASSETS:4,6153,9133,4012,8792,3262,1841,884
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:18714816617110410385
Accounts payable410238887
Accrued liabilities183139143163969678
Employee-related liabilities      28
Other undisclosed accounts payable and accrued liabilities      (28)
Debt 252   50
Other liabilities40403834345710
Other undisclosed current liabilities972372240195275409
Total current liabilities:323463277445333441504
Noncurrent Liabilities
Long-term debt and lease obligation800600     
Long-term debt, excluding current maturities800600     
Liabilities, other than long-term debt97706764131144115
Other liabilities97706764131144115
Other undisclosed noncurrent liabilities  250250   
Total noncurrent liabilities:897670317314131144115
Total liabilities:1,2201,133593758463585619
Temporary equity, carrying amount  1919111123
Stockholders' equity
Stockholders' equity attributable to parent3,3952,7802,7892,1021,8511,5891,242
Common stock1111111
Treasury stock, value(2,579)(2,579)(2,579)(2,579)(2,380)(1,902)(1,186)
Additional paid in capital2,1492,0481,9401,8541,8141,7911,376
Accumulated other comprehensive loss(14)(14)(8)(20)(17)(20)(17)
Retained earnings3,8393,3253,4352,8462,4341,7201,068
Total stockholders' equity:3,3952,7802,7892,1021,8511,5891,242
TOTAL LIABILITIES AND EQUITY:4,6153,9133,4012,8792,3262,1841,884

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1,4831,4491,6281,7251,5991,4661,289
Revenue, net1,7251,5991,4661,289
Cost of revenue(359)(391)(199)(315)(73)(418)(126)
Cost of goods and services sold(108)(118)(199)(106)(73)(69)(126)
Other undisclosed gross profit      (9)
Gross profit:1,1241,0581,4291,4101,5261,0481,154
Operating expenses(531)(1,245)(624)(595)(464)(349)(625)
Other undisclosed operating income      10
Operating income (loss):594(188)8058151,062699539
Nonoperating income (expense)4523(47)(45)(2)345(14)
Investment income, nonoperating294429(50)   
Other nonoperating income (expense)4923(8)13204
Interest and debt expense(24)(44)(14)(9)(4)(5)(18)
Income (loss) from continuing operations before equity method investments, income taxes:615(209)7457611,0561,040508
Other undisclosed income from continuing operations before income taxes24441494518
Income (loss) from continuing operations before income taxes:639(165)7597701,0601,044525
Income tax expense (benefit)(124)61(170)(352)(347)(393)(185)
Net income (loss) available to common stockholders, diluted:515(105)589418714652340

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):515(105)589418714652340
Other comprehensive income   1111
Comprehensive income (loss):515(105)589419715653342
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (6)12(4)3(5)(5)
Comprehensive income (loss), net of tax, attributable to parent:515(111)601415717648337

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: